Bretazenil | |
---|---|
Molecular structure via molpic based on CDK |
Physical properties [] | |
---|---|
Molecular mass | 418.3 g/mol [1] |
Predicted LogP | 3.1 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C19H20BrN3O3 [1] |
IUPAC name | tert-butyl (7S)-14-bromo-12-oxo-2,4,11-triazatetracyclo[11.4.0.02,6.07,11]heptadeca-1(17),3,5,13,15-pentaene-5-carboxylate [1] |
SMILES | CC(C)(C)OC(=O)C1=C2[C@@H]3CCCN3C(=O)C4=C(N2C=N1)C=CC=C4Br [1] |
InChI | InChI=1S/C19H20BrN3O3/c1-19(2,3)26-18(25)15-16-13-8-5-9-22(13)17(24)14-11(20)6-4-7-12(14)23(16)10-21-15/h4,6-7,10,13H,5,8-9H2,1-3H3/t13-/m0/s1 [1] |
InChIKey | LWUDDYHYYNNIQI-ZDUSSCGKSA-N [1] |
Bretazenil
Bretazenil (also known as Bretazenilum, Ro 16-6028/000, Ro-166028000, Ro-f61816-6028/000, RefChem:917541, t-butyl-8-bromo-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo(1,5-a)-pyrrolo(2,1-c)(1,4)benzodiazepine-1-carboxylate, 9H-Imidazo(1,5-a)pyrrolo(2,1-c)(1,4)benzodiazepine-1-carboxylic acid, 8-bromo-11,12,13,13a-tetrahydro-9-oxo-,1,1-dimethylethyl ester, (S)-, Ro 16-6028, Ro-16-6028 or Ncgc00160640-01) is a
Chemistry
Stereochemistry []
Bretazenil is a absolute mixture
Anodyne Usernotes [] | |
---|---|
magnus / Bretazenil via Oral | - |
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 107926, Bretazenil. Accessed September 1, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/107926
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Bretazenil. UNII: OSZ0E9DGOJ. Global Substance Registration System. Accessed September 1, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/OSZ0E9DGOJ